Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

New Microdevice Enables Culture of Rare Circulating Tumor Cells from Blood

April 25, 2012 By AxoGen, Inc.

A research collaboration between the Wyss Institute for
Biologically Inspired Engineering at Harvard
University and Childrens
Hospital Boston has created a microfluidic device that can harvest rare
circulating tumor cells (CTCs) from blood to enable their expansion in culture
for analysis. These cells, which have detached from a primary cancer site and
often create a secondary — or metastasized — tumor, hold an extraordinary
amount of information regarding patient-specific drug sensitivity, cancer
progression, and patient response to therapy. Such information could help
clinicians treat patients, but it has not been easily accessed due to the
difficulty of isolating CTCs and expanding them in culture for subsequent
analysis. In alleviating this problem, the new technology has the potential to
become a valuable tool for cancer diagnosis and personalized treatment. The
research findings appear online in the journal Lab on a Chip.

Wyss Founding Director, Donald Ingber, M.D., Ph.D., and Wyss
Postdoctoral Fellow Joo Kang, Ph.D., led the research team. Ingber is the Judah
Folkman Professor of Vascular Biology at Harvard Medical School (HMS) and the
Vascular Biology Program at Children’s Hospital Boston, and Professor of
Bioengineering at Harvard’s School
of Engineering and
Applied Sciences. Kang is a Research Fellow at Childrens Hospital. Also on the
team were Wyss Postdoctoral Fellow Mathumai Kanapathipillai; Childrens
Hospital Research Fellow Silva Krause and Research Associate Heather Tobin; and
Akiko Mammoto, an Instructor in Surgery at HMS and Childrens Hospital.

This novel approach for capturing and culturing CTCs
combines micromagnetics and microfluidics within a cell-separation device,
about the size of a credit card, in which microfluidic channels have been molded
into a hard clear polymer. As blood flows through these channels, magnetic
beads that have been coated to selectively stick to the CTCs are used to
separate them from the other cells in the blood. The dimensions of the channels
have been designed to protect CTCs from mechanical stresses that might alter
their structure or biochemistry, as well as to maximize the number of CTCs that
can be captured.

In the lab, the new approach demonstrated extremely high
efficiency by capturing more than 90 percent of CTCs from the blood of mice
with breast cancer. Of particular significance was the fact that the captured
CTCs were able to be grown and expanded in culture. These intact living tumor
cells could be used for additional testing and molecular analysis, for example,
in screening drugs to meet the personal needs of individual patients in the
future. Further testing found that the device is sensitive enough to detect the
sudden increases in the number of CTCs that signal a cancers metastatic
transition and could therefore alert clinicians to possible disease
progression.

The Wyss Institute/Childrens Hospital team carried out
their studies with one common type of breast cancer. But the same device could
be used to address a wide range of tumor types as well as applications beyond
cancer, such as collecting circulating stem cells or endothelial progenitor
cells from the blood and growing them for use in organ repair, in the future.

About the Wyss Institute for Biologically Inspired
Engineering at Harvard University

The Wyss Institute for Biologically Inspired Engineering at Harvard University
(http://wyss.harvard.edu) uses Natures design principles to develop
bioinspired materials and devices that will transform medicine and create a
more sustainable world. Working as an alliance among Harvards Schools of
Medicine, Engineering, and Arts & Sciences, and in partnership with Beth
Israel Deaconess Medical Center, Brigham and Womens Hospital, Childrens
Hospital Boston, Dana Farber Cancer Institute, Massachusetts General Hospital,
the University of Massachusetts Medical School, Spaulding Rehabilitation
Hospital, and Boston University, the Institute crosses disciplinary and
institutional barriers to engage in high-risk research that leads to
transformative technological breakthroughs. By emulating Natures principles
for self-organizing and self-regulating, Wyss researchers are developing
innovative new engineering solutions for healthcare, energy, architecture,
robotics, and manufacturing. These technologies are translated into commercial
products and therapies through collaborations with clinical investigators,
corporate alliances, and new start-ups.

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech